Mega Cap
Drug Manufacturers - General
Stocks Ranked by
Market Capitalization
Major, global pharmaceutical manufacturers offering a broad and diverse line of drug and healthcare products; industry leaders that have made a significant commitment to the research and development of a long pipeline of drugs.
| Name | Market cap | Price |
Price change % |
|
|---|---|---|---|---|
1
Eli Lilly
LLY
$658B
| $658B | $731.96 | 0.3% |
|
2
Johnson & Johnson
JNJ
$426B
| $426B | $175.45 | 0.76% |
|
3
AbbVie
ABBV
$368B
| $368B | $207.92 | 0.07% |
|
4
Novo Nordisk
NVO
$249B
| $249B | $56.11 | 0.58% |
|
5
AstraZeneca
AZN
$248B
| $248B | $79.99 | 0.08% |
|
6
Novartis
NVS
$246B
| $246B | $126.47 | 0.33% |
|
7
Merck
MRK
$210B
| $210B | $83.21 | 1.02% |
|